Genome engineering startup gets $43M to cut out bad DNA

Editas Medicine, a startup that wants to enable “molecular surgery”  to cut out bad genes before they can manifest themselves, has $43 million in Series A funding from Polaris Partners, Flagship Ventures and Third Rock Ventures.  Co-founder Dr. J.Keith Joung, who is also director of molcular pathology at Mass General Hospital, told The Boston Globe that the idea is to “make changes to DNA … if there’s a defect, you can fix it; if there’s a missing piece you can put the missing piece in.”

Story posted at:

You're subscribed! If you like, you can update your settings


Comments have been disabled for this post